BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29124279)

  • 1. Up-front PET/CT changes treatment intent in patients with head and neck squamous cell carcinoma.
    Rohde M; Nielsen AL; Johansen J; Sørensen JA; Diaz A; Asmussen JT; Gerke O; Thomassen A; Gyldenkerne N; Døssing H; Bjørndal K; Høilund-Carlsen PF; Godballe C
    Eur J Nucl Med Mol Imaging; 2018 Apr; 45(4):613-621. PubMed ID: 29124279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upfront PET/CT affects management decisions in patients with recurrent head and neck squamous cell carcinoma.
    Rohde M; Nielsen AL; Johansen J; Sørensen JA; Diaz A; Pareek M; Asmussen JT; Gerke O; Thomassen A; Gyldenkerne N; Døssing H; Bjørndal K; Høilund-Carlsen PF; Godballe C
    Oral Oncol; 2019 Jul; 94():1-7. PubMed ID: 31178202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET/CT Versus Standard Imaging for Prediction of Survival in Patients with Recurrent Head and Neck Squamous Cell Carcinoma.
    Rohde M; Nielsen AL; Pareek M; Johansen J; Sørensen JA; Diaz A; Nielsen MK; Christiansen JM; Asmussen JT; Nguyen N; Gerke O; Thomassen A; Alavi A; Høilund-Carlsen PF; Godballe C
    J Nucl Med; 2019 May; 60(5):592-599. PubMed ID: 30315144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis.
    Cacicedo J; Fernandez I; Del Hoyo O; Dolado A; Gómez-Suarez J; Hortelano E; Sancho A; Pijoan JI; Alvarez J; Espinosa JM; Gaafar A; Bilbao P
    Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1378-89. PubMed ID: 25952280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-fluoro-deoxy-glucose-positron emission tomography/computed tomography in diagnosis of head and neck squamous cell carcinoma: a systematic review and meta-analysis.
    Rohde M; Dyrvig AK; Johansen J; Sørensen JA; Gerke O; Nielsen AL; Høilund-Carlsen PF; Godballe C
    Eur J Cancer; 2014 Sep; 50(13):2271-9. PubMed ID: 25011659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head-to-Head Comparison of Chest X-Ray/Head and Neck MRI, Chest CT/Head and Neck MRI, and
    Rohde M; Nielsen AL; Johansen J; Sørensen JA; Nguyen N; Diaz A; Nielsen MK; Asmussen JT; Christiansen JM; Gerke O; Thomassen A; Alavi A; Høilund-Carlsen PF; Godballe C
    J Nucl Med; 2017 Dec; 58(12):1919-1924. PubMed ID: 28572489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A PET/CT-Based Strategy Is a Stronger Predictor of Survival Than a Standard Imaging Strategy in Patients with Head and Neck Squamous Cell Carcinoma.
    Rohde M; Nielsen AL; Pareek M; Johansen J; Sørensen JA; Diaz A; Nielsen MK; Christiansen JM; Asmussen JT; Nguyen N; Gerke O; Thomassen A; Alavi A; Høilund-Carlsen PF; Godballe C
    J Nucl Med; 2018 Apr; 59(4):575-581. PubMed ID: 28864630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of only 18F-fluorodeocyglucose positron emission tomography/computed tomography-positive lymph nodes in head and neck squamous cell carcinoma.
    Lee SH; Huh SH; Jin SM; Rho YS; Yoon DY; Park CH
    Otolaryngol Head Neck Surg; 2012 Oct; 147(4):692-8. PubMed ID: 22535915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT.
    Krabbe CA; Pruim J; van der Laan BF; Rödiger LA; Roodenburg JL
    Oral Oncol; 2009 Mar; 45(3):234-40. PubMed ID: 18715818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer.
    Schinagl DA; Vogel WV; Hoffmann AL; van Dalen JA; Oyen WJ; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1282-9. PubMed ID: 17967318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Intensive 18F-Fludeoxyglucose-Positron Emission Tomography With Computed Tomography-Based Strategy of Follow-Up in Patients Treated for Head and Neck Squamous Cell Carcinoma Who Are Clinically Asymptomatic.
    Leclère JC; Clément C; Le Pennec R; Maheo C; Gujral DM; Schick U; Le Gal G; Marianowski R; Salaun PY; Abgral R
    JAMA Netw Open; 2023 Aug; 6(8):e2326654. PubMed ID: 37526935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study.
    Lonneux M; Hamoir M; Reychler H; Maingon P; Duvillard C; Calais G; Bridji B; Digue L; Toubeau M; Grégoire V
    J Clin Oncol; 2010 Mar; 28(7):1190-5. PubMed ID: 20124179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma.
    Bogowicz M; Riesterer O; Stark LS; Studer G; Unkelbach J; Guckenberger M; Tanadini-Lang S
    Acta Oncol; 2017 Nov; 56(11):1531-1536. PubMed ID: 28820287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter Trial of [
    Lowe VJ; Duan F; Subramaniam RM; Sicks JD; Romanoff J; Bartel T; Yu JQM; Nussenbaum B; Richmon J; Arnold CD; Cognetti D; Stack BC
    J Clin Oncol; 2019 Jul; 37(20):1704-1712. PubMed ID: 30768363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
    Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of PET/CT imaging performed early after surgical resection in the adjuvant treatment planning for head and neck cancer.
    Shintani SA; Foote RL; Lowe VJ; Brown PD; Garces YI; Kasperbauer JL
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):322-9. PubMed ID: 17889447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance.
    Helsen N; Van den Wyngaert T; Carp L; Stroobants S
    Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):1063-1071. PubMed ID: 29478080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
    Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET/CT for Head and Neck Squamous Cell Carcinoma: Should We Routinely Include the Head and Abdomen?
    Yankevich U; Hughes MA; Rath TJ; Fakhran S; Alhilahi LM; Seungwon KW; Branstetter BF
    AJR Am J Roentgenol; 2017 Apr; 208(4):844-848. PubMed ID: 28177644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.